US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Gastrointestinal Market Research Reports & Industry Analysis

RSS Feeds

Gastrointestinal Industry Research & Market Reports

3  4  5  6    8    10  11  12  
France Irritable Bowel Syndrome Market Highlights – 2015
9/1/2015 | published by: Fore Pharma
... forecast in France. The research includes France irritable bowel syndrome market size estimates for 2014, market share forecast for six years to 2020, irritable bowel syndrome drugs market share, irritable bowel syndrome drugs sales estimates, ...  |  read more...
USD 990
Italy Irritable Bowel Syndrome Market Highlights – 2015
9/1/2015 | published by: Fore Pharma
... forecast in Italy. The research includes Italy irritable bowel syndrome market size estimates for 2014, market share forecast for six years to 2020, irritable bowel syndrome drugs market share, irritable bowel syndrome drugs sales estimates, ...  |  read more...
USD 990
Japan Irritable Bowel Syndrome Market Highlights – 2015
9/1/2015 | published by: Fore Pharma
... forecast in Japan. The research includes Japan irritable bowel syndrome market size estimates for 2014, market share forecast for six years to 2020, irritable bowel syndrome drugs market share, irritable bowel syndrome drugs sales estimates, ...  |  read more...
USD 990
US Irritable Bowel Syndrome Market Highlights – 2015
9/1/2015 | published by: Fore Pharma
... sales forecast in the US. The research includes the US irritable bowel syndrome market size estimates for 2014, market share forecast for six years to 2020, irritable bowel syndrome drugs market share, irritable bowel syndrome ...  |  read more...
USD 990
Europe Irritable Bowel Syndrome Market Highlights – 2015
9/1/2015 | published by: Fore Pharma
... for Germany, France, Italy, Spain, and UK. The research includes Europe (Germany, France, Italy, Spain, and UK) irritable bowel syndrome market size estimates for 2014, market share forecast for six years to 2020, irritable bowel ...  |  read more...
USD 2,800
Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market 2015-2019
8/5/2015 | published by: TechNavio - Infiniti Research Ltd.
... chemotherapy treatment for cancer. This nausea and vomiting, associated with chemotherapy regimen, affects the quality of life of an individual. The neurotransmitters in CINV are dopamine, 5-HT3, substance P, and endocannabinoids. CINV can be caused ...  |  read more...
USD 2,500
Trends to Watch in Digestive Health
9/25/2015 | published by: Canadean Ltd
... products and their purchasing habits within the OTC category. Synopsis Identify five emerging trends influencing innovation in the OTC digestive health space, including the latest on-trend innovation examples. Understand how consumer trends such as Fresh ...  |  read more...
USD 995
Global GERD Market 2016-2020
1/20/2016 | published by: TechNavio - Infiniti Research Ltd.
... when acidic stomach juices, or food and fluids flow back up into the food pipe (esophagus). The backwash irritates the lining of the esophagus and causes GERD. It affects all ages from infants to older ...  |  read more...
USD 2,500
Digestive Remedies in Croatia
12/3/2015 | published by: Euromonitor International
... natural product forms. Since 2005 the share of herbal/traditional digestive remedies has risen from 17% to 23% of total value sales. Consumers are increasingly seeking products with minimal potential side effects, and they seem to ...  |  read more...
USD 990
Gastroenteritis - Pipeline Review, H2 2015
11/25/2015 | published by: Global Markets Direct
... Gastroenteritis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Digestive Remedies in Mexico
12/17/2015 | published by: Euromonitor International
... first of many moves by Casa Saba after declaring itself bankrupt. As the leading distributor, this sale negatively affected many Rx and OTC categories, with digestive remedies being no exception. According to trade interviews, OTC ...  |  read more...
USD 990
Digestive Remedies in Taiwan
12/22/2015 | published by: Euromonitor International
... dine out anywhere and anytime. However, a series of food security issues in 2014 proved that meals consumers take in foodservice can actually be harmful to the body. That is why many people tend to ...  |  read more...
USD 990
Digestive Remedies in the US
12/21/2015 | published by: Euromonitor International
... and high in processed foods, which increases the need for laxatives and other digestive aids. Increasingly fast-paced and stressful lifestyles also impact consumers’ digestive systems, as the gut is especially vulnerable to tension. Stress will ...  |  read more...
USD 990
Constipation-Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. ...  |  read more...
USD 1,250
Dyspepsia-Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. ...  |  read more...
USD 1,250
Functional (Non Ulcer) Dyspepsia-Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent ...  |  read more...
USD 1,250
Gastritis-Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. ...  |  read more...
USD 1,250
Gastroesophageal (GE) Junction Carcinomas-Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent ...  |  read more...
USD 1,250
Gastrointestinal Bleeding-Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ...  |  read more...
USD 1,250
Gastrointestinal Tract Cancer-Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA ...  |  read more...
USD 1,250
Helicobacter Pylori Infections-Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA ...  |  read more...
USD 1,250
Traveler's Diarrhea-Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ...  |  read more...
USD 1,250
Acid Indigestion / Heartburn/ Pyrosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
1/1/2016 | published by: DelveInsight
... the globe. A key objective of the Acid Indigestion / Heartburn/ Pyrosis Report is to understand the market and pipeline status of the drugs around the Acid Indigestion / Heartburn/ Pyrosis to explore the generic ...  |  read more...
USD 2,000
Gastritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
1/1/2016 | published by: DelveInsight
... objective of the Gastritis Report is to understand the market and pipeline status of the drugs around the Gastritis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline ...  |  read more...
USD 2,000
Gastrointestinal Stromal Tumor (GIST)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
1/1/2016 | published by: DelveInsight
... globe. A key objective of the Gastrointestinal Stromal Tumor (GIST) Report is to understand the market and pipeline status of the drugs around the Gastrointestinal Stromal Tumor (GIST) to explore the generic development opportunities, licensing ...  |  read more...
USD 2,000
3  4  5  6    8    10  11  12